Zobrazeno 1 - 10
of 36
pro vyhledávání: '"J C, Meijers"'
Autor:
A J, Vlot, S J, Koppelman, J C, Meijers, C, Dama, H M, van den Berg, B N, Bouma, J J, Sixma, G M, Willems
Publikováno v:
Blood. 87:1809-1816
The binding of factor VIII to von Willebrand factor (vWF) is essential for the protection of factor VIII against proteolytic degradation in plasma. We have characterized the binding kinetics of human factor VIII with vWF using a centrifugation bindin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7afffeab4e239efe8f2dc149681cd56
https://doi.org/10.1182/blood.v87.5.1809.bloodjournal8751809
https://doi.org/10.1182/blood.v87.5.1809.bloodjournal8751809
Publikováno v:
Blood. 86:3035-3042
Recently, an alternative pathway for factor XI activation has been described in which factor XI is activated by thrombin. Patients with a factor XI deficiency bleed mostly from tissues with high local fibrinolytic activity. Therefore, the role of thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8047f4894947ae767a6afcd5ad8736e
https://doi.org/10.1182/blood.v86.8.3035.bloodjournal8683035
https://doi.org/10.1182/blood.v86.8.3035.bloodjournal8683035
Publikováno v:
Blood. 79:1435-1440
Human factor XI (FXI) is a blood coagulation factor participating in the early phase of the intrinsic pathway of blood coagulation. It circulates in blood as a glycoprotein composed of two identical chains held together by a single disulfide bond bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c9f89f607831f4120420cfcb10ae6f
https://doi.org/10.1182/blood.v79.6.1435.bloodjournal7961435
https://doi.org/10.1182/blood.v79.6.1435.bloodjournal7961435
Publikováno v:
Thrombosis and haemostasis. 86(4)
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) is a carboxy-peptidase B-like proenzyme that after activation by thrombin down regulates fibrinolysis. Thrombomodulin (TM) stimulates the activation of both TAFI and protein C whereas activated prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::af0f33261c0462bfb8f3f8ff5a3cb2a2
https://pubmed.ncbi.nlm.nih.gov/11686324
https://pubmed.ncbi.nlm.nih.gov/11686324
Publikováno v:
Thrombosis and haemostasis. 86(4)
TAFI (thrombin activatable fibrinolysis inhibitor) down regulates fibrinolysis after activation by relatively high concentrations of thrombin generated during coagulation via thrombin mediated factor XI activation and subsequent activation of the int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc956bf36142cc36dc20981916df3e9d
https://pubmed.ncbi.nlm.nih.gov/11686321
https://pubmed.ncbi.nlm.nih.gov/11686321
Publikováno v:
Thrombosis and haemostasis. 86(4)
Thrombin activatable fibrinolysis inhibitor (TAFI) is a carboxy-peptidase B-like proenzyme that after activation by thrombin downregulates fibrinolysis. Thrombomodulin stimulates the activation of both TAFI and protein C whereas activated protein C i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::272a8cabe109543fff6c1e99ca1b2011
https://pubmed.ncbi.nlm.nih.gov/11686322
https://pubmed.ncbi.nlm.nih.gov/11686322
Autor:
M J, Simmelink, D A, Horbach, R H, Derksen, J C, Meijers, E M, Bevers, G M, Willems, P G, De Groot
Publikováno v:
British journal of haematology. 113(3)
We investigated the mechanism by which anti-prothrombin antibodies cause lupus anticoagulant (LAC) activity. Addition of affinity-purified anti-prothrombin antibodies from LAC-positive plasma samples (alpha-FII-LAC+) to normal plasma induced LAC acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::14ad49e048f1a1de88d73f3ae35b2f57
https://pubmed.ncbi.nlm.nih.gov/11380447
https://pubmed.ncbi.nlm.nih.gov/11380447
Autor:
R F, Franco, M G, Fagundes, J C, Meijers, P H, Reitsma, D, Lourenço, V, Morelli, F H, Maffei, I C, Ferrari, C E, Piccinato, W A, Silva, M A, Zago
Publikováno v:
Haematologica. 86(5)
Thrombin activatable fibrinolysis inhibitor (TAFI) plays an important role in hemostasis, functioning as a potent fibrinolysis inhibitor. TAFI gene variations may contribute to plasma TAFI levels and thrombotic risk.We sequenced a 2083-bp region of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::86ecfeb9934040d1ca9da48a97efe619
https://pubmed.ncbi.nlm.nih.gov/11410415
https://pubmed.ncbi.nlm.nih.gov/11410415
Publikováno v:
Thrombosis and haemostasis. 85(5)
Activated protein C (APC) is an important inactivator of coagulation factors Va and VIIIa. In the inactivation of factors Va and VIIIa, protein S serves as a cofactor to APC. Protein S can bind to C4b-binding protein (C4BP), and thereby loses its cof
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1a59e5d6ebfaadcfa6060db683d6fe4f
https://pubmed.ncbi.nlm.nih.gov/11372662
https://pubmed.ncbi.nlm.nih.gov/11372662
Autor:
E C, van Gorp, M C, Minnema, C, Suharti, A T, Mairuhu, D P, Brandjes, H, ten Cate, C E, Hack, J C, Meijers
Publikováno v:
British journal of haematology. 113(1)
A prospective cohort study was performed in 50 patients with dengue haemorrhagic fever (DHF) to determine the potential role of the contact activation system and factor XI activation (intrinsic pathway) in the coagulation disorders in DHF. To establi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::35a775e378cec47550cf1319a68afa03
https://pubmed.ncbi.nlm.nih.gov/11328287
https://pubmed.ncbi.nlm.nih.gov/11328287